Drawing for STEM20

USPTO serial 85215003

STEM20

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
POVARCHUK, REBECCA JOYCE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with STEM20?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Tracy-Gene G. Durkin

TRACY-GENE G. DURKIN STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.1100 NEW YORK AVE NW STE 600WASHINGTON, DC 20005-6125UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Reagents for scientific use for use in biological processing; biological preparations for scientific use for use in cell cultures; cultures of cell media for scientific use; media for cell culture for use in non-medical research laboratories; media for cell culture for use in the biotechnological industry; biochemicals for scientific use, namely, antibodies and monoclonal antibodies; products, namely, kits comprising antibodies for use in science; tissue culture reagents for scientific and medical laboratory research use; cell culture reagents; cell culture media for scientific use; biological test kits for research use comprising buffers and standard solutions; biological reagents for scientific use for use in embryology; biological reagents for scientific use for use in molecular biologyACTIVE—
005Reagents for medical use for use in biological processing; reagents for veterinary use for use in biological processing; biological preparations for medical use for use in cell cultures; cell culture media, namely, cell culture reagents for medical use; antibodies for immunodiagnostic medical use; antibodies for immunological therapeutic use; monoclonal antibodies for immunodiagnostic medical use; monoclonal antibodies for immunological therapeutic use; products, namely, kits comprising antibodies for use in immunodiagnostic medicine or immunological therapyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 16, 2012MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 16, 2012ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 13, 2011NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 19, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 29, 2011NPUBNOTICE OF PUBLICATION—
Jun 14, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 10, 2011ALIEASSIGNED TO LIE—
May 27, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 27, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 27, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 27, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 29, 2011CPRAPRIORITY ACTION MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Mar 28, 2011CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Mar 21, 2011DOCKASSIGNED TO EXAMINER—
Jan 15, 2011MPMKNOTICE OF PSEUDO MARK MAILED—
Jan 14, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 14, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance